Ældre patienter, som får CellCept som del af en immunsuppressiv kombinationsbehandling, har, sammenlignet med yngre patienter, højere risiko for visse infektioner (inklusiv invasiv vævssygdom forårsaget af cytomegalovirus) og muligvis for gastrointestinal blødning og lungeødem.
Elderly patients receiving CellCept as part of a combination immunosuppressive regimen, may be at increased risk of certain infections (including cytomegalovirus tissue invasive disease) and possibly gastrointestinal haemorrhage and pulmonary oedema, compared to younger individuals.